Provided by Tiger Trade Technology Pte. Ltd.

Protagenic Therapeutics Inc

0.4722
+0.052212.42%
Volume:11.06K
Turnover:4.01K
Market Cap:913.59K
PE:-0.09
High:0.5094
Open:0.3901
Low:0.3501
Close:0.4200
52wk High:14.28
52wk Low:0.2500
Shares:1.93M
Float Shares:1.91M
Volume Ratio:1.73
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.3030
EPS(LYR):-15.7868
ROE:-512.79%
ROA:-189.60%
PB:-10.34
PE(LYR):-0.03

Loading ...

Company Profile

Company Name:
Protagenic Therapeutics Inc
Exchange:
PINK
Establishment Date:
2004
Employees:
- -
Office Location:
701 Anacapa Street,Suite C,Santa Barbara,California,United States
Zip Code:
93101
Fax:
- -
Introduction:
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.